A detailed history of Jane Street Group, LLC transactions in Zomedica Corp. stock. As of the latest transaction made, Jane Street Group, LLC holds 179,074 shares of ZOM stock, worth $23,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares
179,074
Holding current value
$23,279
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.12 - $0.16 $21,488 - $28,651
179,074 New
179,074 $25,000
Q1 2024

May 15, 2024

SELL
$0.12 - $0.19 $22,925 - $36,298
-191,047 Reduced 58.44%
135,872 $20,000
Q4 2023

Feb 14, 2024

BUY
$0.15 - $0.22 $45,797 - $67,169
305,317 Added 1413.37%
326,919 $65,000
Q3 2023

Nov 14, 2023

SELL
$0.16 - $0.23 $37,477 - $53,874
-234,235 Reduced 91.56%
21,602 $3,000
Q2 2023

Aug 14, 2023

SELL
$0.19 - $0.22 $131,512 - $152,278
-692,173 Reduced 73.01%
255,837 $51,000
Q1 2023

May 15, 2023

BUY
$0.16 - $0.29 $108,525 - $196,701
678,282 Added 251.47%
948,010 $199,000
Q4 2022

Feb 14, 2023

BUY
$0.16 - $0.25 $16,662 - $26,035
104,143 Added 62.89%
269,728 $43,000
Q3 2022

Nov 14, 2022

SELL
$0.2 - $0.38 $183,335 - $348,336
-916,676 Reduced 84.7%
165,585 $35,000
Q2 2022

Aug 16, 2022

BUY
$0.2 - $0.34 $174,329 - $296,359
871,646 Added 413.86%
1,082,261 $238,000
Q1 2022

May 17, 2022

SELL
$0.28 - $0.4 $91,205 - $130,293
-325,734 Reduced 60.73%
210,615 $71,000
Q4 2021

Feb 15, 2022

SELL
$0.31 - $0.58 $36,464 - $68,223
-117,626 Reduced 17.99%
536,349 $164,000
Q3 2021

Nov 16, 2021

BUY
$0.46 - $0.81 $281,792 - $496,199
612,592 Added 1480.3%
653,975 $342,000
Q2 2021

Aug 16, 2021

BUY
$0.72 - $1.46 $29,795 - $60,419
41,383 New
41,383 $34,000
Q1 2021

May 18, 2021

SELL
$0.35 - $2.7 $26,297 - $202,869
-75,137 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$0.07 - $0.25 $5,259 - $18,784
75,137 New
75,137 $17,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.